Depression
Depressive disorders are a major public health problem that are reaching epidemic levels in the United States. Approximately 38 million American adults are affected by depressive disorders a year. Common symptoms include being anxious, obessession, sadness, negative thoughts, headaches, feelings of hopelessness, mood swings, irritability, and sleep and appetite problems. The medical profession itself sometimes struggles with accurately diagnosing major depressive disorders. There is a high degree of variation in symptoms, course of illness and response to treatment that make accurate diagnosis difficult. It is not uncommon for individuals with depression to undergo multiple misdiagnoses, and receive clinical care with a trial and error approach.
Acknowledging that the diagnosis of depressive disorders is challenging only addresses part of the concern. Even though nearly 90% of individuals are able to be treated successfully, only one third of these diagnosed even seek help. Not only are patients faced with the possibility of conflicting diagnosis and treatment, but they also fall victim to the stigma attached to emotional difficulties. The majority of Americans do not believe that depression is actually a health problem. These individuals consider it a weakness of character or will, and not a legitimate medical illness.
SPECT imaging can help individuals with depressive disorders visualize what is happening in their brain on a physical level. When a patient can actually see that the parts of the brain associated with depression and mood disorders are not functioning properly, he or she can better accept that their mood swings and hopelessness are not emotional flaws. Brain SPECT imaging, along with a detailed patient history and existing clinical treatment, provides more accurate information for specific, effective treatment plans. Once patients understand their illness, and can trust that the diagnosis is as accurate as possible, their commitment to comply with treatment is increased dramatically.